the patient-focused impact assessment act of 2015 .
this bill amends the federal food, drug, and cosmetic act to require the food and drug administration (fda) to prepare and submit to the food and drug administration of the department of health and human services (hhs) the patient engagement assessment efforts made as part of the patient-focused drug development tools and data reviewed in informing the decision to approve the study, and including an explanation of whether the following were reviewed patient population benefit and risk efforts; draft or final guidances issued by the food and drug administration.